| High-throughput mapping of B cell receptor sequences to antigen specificity I Setliff, AR Shiakolas, KA Pilewski, AA Murji, RE Mapengo, K Janowska, ... Cell 179 (7), 1636-1646. e15, 2019 | 241 | 2019 |
| Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions AR Shiakolas, KJ Kramer, D Wrapp, SI Richardson, A Schäfer, S Wall, ... Cell Reports Medicine 2 (6), 2021 | 61 | 2021 |
| Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine KJ Kramer, EM Wilfong, K Voss, SM Barone, AR Shiakolas, N Raju, ... Nature Communications 13 (1), 3466, 2022 | 37 | 2022 |
| Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking AR Shiakolas, KJ Kramer, NV Johnson, SC Wall, N Suryadevara, ... Nature biotechnology 40 (8), 1270-1275, 2022 | 32 | 2022 |
| Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition KJ Kramer, NV Johnson, AR Shiakolas, N Suryadevara, S Periasamy, ... Cell Reports 37 (1), 2021 | 24 | 2021 |
| An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer N Suryadevara, AR Shiakolas, LA VanBlargan, E Binshtein, RE Chen, ... The Journal of Clinical Investigation 132 (11), 2022 | 16 | 2022 |
| Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis Q Howlett-Prieto, X Feng, JF Kramer, KJ Kramer, TW Houston, AT Reder Multiple Sclerosis Journal 27 (14), 2170-2179, 2021 | 12 | 2021 |
| Single source “solar thermal” heat pump for residential heat supply: Performance with an array of unglazed PVT collectors C Schmidt, A Schäfer, K Kramer 12th ISES Eurosun Conference, 2018 | 6 | 2018 |
| Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor KA Pilewski, S Wall, SI Richardson, NP Manamela, K Clark, T Hermanus, ... Cell reports 42 (2), 2023 | 5 | 2023 |
| Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions AR Shiakolas, KJ Kramer, D Wrapp, SI Richardson, A Schäfer, S Wall, ... bioRxiv, 2020.12. 20.414748, 2020 | 5 | 2020 |
| Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking AR Shiakolas, N Johnson, KJ Kramer, N Suryadevara, D Wrapp, ... bioRxiv, 2021.06. 02.446813, 2021 | 4 | 2021 |
| Simultaneous immunization with multiple diverse immunogens alters development of antigen-specific antibody-mediated immunity KA Pilewski, KJ Kramer, IS Georgiev Vaccines 9 (9), 964, 2021 | 2 | 2021 |
| Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody NV Johnson, S Wall, K Kramer, C Holt, S Periasamy, S Richardson, ... bioRxiv, 2024.01. 15.575741, 2024 | 1 | 2024 |
| Effect of PO2 and metabolic inhibitors on ionic fluxes across the isolated rabbit corneal endothelium. K Green, L Cheeks, E Armstrong, R Berdecia, K Kramer, DS Hull Lens and eye toxicity research 7 (2), 103-119, 1990 | 1 | 1990 |
| Sars-cov-2 coronavirus antibodies and uses thereof IS Georgiev, AR Shiakolas, KJ Kramer US Patent App. 18/273,625, 2024 | | 2024 |
| Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody (preprint) NV Johnson, S Wall, K Kramer, C Holt, S Periasamy, S Richardson, ... | | 2024 |
| Cross-reactive coronavirus antibodies and uses thereof IS Georgiev, AR Shiakolas, KJ Kramer, JE Crowe Jr, R Carnahan, ... US Patent App. 17/917,174, 2023 | | 2023 |
| Therapeutic antibodies for treating lung cancer KJ Kramer, I Georgiev US Patent App. 17/600,862, 2022 | | 2022 |
| An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer (preprint) N Suryadevara, A Shiakolas, L VanBlargan, E Binshtein, R Chen, ... | | 2022 |
| Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking (preprint) AR Shiakolas, N Johnson, KJ Kramer, N Suryadevara, D Wrapp, ... | | 2021 |
